Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia

Published:2005-05 Issue:5 Volume:27 Page:273-277
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Ercan Tugba Erener,Soycan Lebriz Yüksel,Apak Hilmi,Celkan Tiraje,Ozkan Alp,Akdenizli Emine,Kasapçopur Ozgur,Yildiz Inci

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference29 articles.

1. Childhood acute lymphoblastic leukaemia: current status and future perspectives.;Pui;Lancet Oncol,2001

2. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia.;Alanko;Cancer,1992

3. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy.;Smith;J Pediatr,1995

4. Immunization response varies with intensity of acute lymphoblastic leukemia therapy.;Ridgway;Am J Dis Child,1991

5. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogenic bone marrow transplantation.;Parkkali;APMIS,1996

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine Immunity in Children After Hematologic Cancer Treatment: A Retrospective Single-center Study;Journal of Pediatric Hematology/Oncology;2023-11-03

2. Vaccinations in children with hematologic malignancies and those receiving hematopoietic stem cell transplants or cellular therapies;Transplant Infectious Disease;2023-07-12

3. COVID-19 vaccination in patients with cancer: Opportunities and challenges;Frontiers in Oncology;2022-11-08

4. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations;Clinical and Applied Thrombosis/Hemostasis;2022-01

5. Administration of COVID-19 vaccines in immunocompromised patients;International Immunopharmacology;2021-10